Search Results - "LJUNGCRANTZ, I."

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine by Wigren, M., Kolbus, D., Dunér, P., Ljungcrantz, I., Söderberg, I., Björkbacka, H., Fredrikson, G. N., Nilsson, J.

“…  Wigren M, Kolbus D, Dunér P, Ljungcrantz I, Söderberg I, Björkbacka H, Fredrikson GN, Nilsson J. (Malmö University Hospital, Lund University; Malmö…”
Get full text

Association between CD8+ T‐cell subsets and cardiovascular disease by Kolbus, D., Ljungcrantz, I., Andersson, L., Hedblad, B., Fredrikson, G. N., Björkbacka, H., Nilsson, J.

“…Background The findings of experimental studies suggest that the immune system plays a key role in atherosclerosis, but the clinical importance of different…”
Get full text

Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B‐100 transgenic mice without inducing an increase in peptide‐specific antibodies by Fredrikson, G. N., Björkbacka, H., Söderberg, I., Ljungcrantz, I., Nilsson, J.

“… Objectives.  Autoantibodies to apolipoprotein (apo) B‐100 peptides are present in human plasma and have been shown to be associated with decreased…”
Get full text

CD4+CD56+ natural killer T‐like cells secreting interferon‐γ are associated with incident coronary events by Björkbacka, H., Berg, K. E., Manjer, J., Engelbertsen, D., Wigren, M., Ljungcrantz, I., Andersson, L., Hedblad, B., Fredrikson, G. N., Nilsson, J.

“…Background CD3+CD56+ natural killer T (NKT)‐like cells are a subset of T cells characterized by expression of NK receptors and potent antitumour activity. It…”
Get full text

IL-25 expands innate lymphoid cells type 2 and inhibits atherosclerosis development in apoe deficient mice by Fredrikson, G. Nordin, Mantani, P.T, Dunér, P, Bengtsson, E, Alm, R, Ljungcrantz, I, Söderberg, I, Sundius, L, To, F, Nilsson, J, Björkbacka, H

Get full text

The presence of elafin, SLPI, IL1‐RA and STNFα RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation by Westin, U., Nyström, M., Ljungcrantz, I., Eriksson, B., Ohlsson, K.

“…Biopsy samples of head and neck carcinomas were investigated with regard to elafin, secretory leukocyte protease inhibitor (SLPI), interleukin 1‐receptor…”
Get full text

S100A9 blockade ameliorates cardiac dysfunction and reduces myocardial immune infiltration in experimental autoimmune myocarditis by Jakobsson, G, Mulholland, M, Grentzmann, A, Ljungcrantz, I, Rattik, S, Engelbertsen, D, Schiopu, A

“…Abstract Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): Swedish Heart and Lung Foundation and Swedish…”
Get full text

Inhibition of S100A9 function has immunomodulatory and cardioprotective effects in experimental autoimmune myocarditis by Jakobsson, G., Mulholland, M., Grentzmann, A., Ljungcrantz, I., Rattik, S., Engelbertsen, D., Schiopu, A.

Get full text

IL-1RAP blockade reduces atherosclerosis and limits plaque inflammation by Mulholland, M., Jakobsson, G., Ljungcrantz, I., Grentzmann, A., Grönberg, C., Rattik, S., Schiopu, A., Björkbacka, H., Engelbertsen, D.

Get full text

Interleukin‐1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies by GOTTSÄTER, A., FORSBLAD, J., MÄTZSCH, T., PERSSON, K., LJUNGCRANTZ, I., OHLSSON, K., LINDGÄRDE, F.

“… Gottsäter A, Forsblad J, Mätzsch T, Persson K, Ljungcrantz I, Ohlsson K, Lindgärde F (Malmö University Hospital, University of Lund, Malmö, Sweden)…”
Get full text

IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice by Mulholland, Megan, Jakobsson, Gabriel, Lei, Yu, Sundius, Lena, Ljungcrantz, Irena, Rattik, Sara, Tietge, Uwe J.F., Engelbertsen, Daniel

“…The relationship between inflammation and lipid metabolism is complex and bidirectional. Lymphocyte-driven inflammation has been shown to modulate both…”
Get full text

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus by Yao Mattisson, Ingrid, Rattik, Sara, Björkbacka, Harry, Ljungcrantz, Irena, Terrinoni, Manuela, Lebens, Michael, Holmgren, Jan, Fredrikson, Gunilla Nordin, Gullstrand, Birgitta, Bengtsson, Anders A., Nilsson, Jan, Wigren, Maria

“…Patients suffering from systemic lupus erythematosus (SLE) are at increased risk of developing cardiovascular disease (CVD) and traditional therapies including…”
Get full text

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice by Rattik, Sara, Mantani, Polyxeni T., Yao Mattisson, Ingrid, Ljungcrantz, Irena, Sundius, Lena, Björkbacka, Harry, Terrinoni, Manuela, Lebens, Michael, Holmgren, Jan, Nilsson, Jan, Wigren, Maria, Nordin Fredrikson, Gunilla

“…Intranasal immunization with a fusion protein of the ApoB100-derived peptide p210 and the cholera toxin B subunit (CTB-p210) has previously been shown to…”
Get full text

CD 4 + CD 56 + natural killer T‐like cells secreting interferon‐γ are associated with incident coronary events by Björkbacka, H., Berg, K. E., Manjer, J., Engelbertsen, D., Wigren, M., Ljungcrantz, I., Andersson, L., Hedblad, B., Fredrikson, G. N., Nilsson, J.

“…Abstract Background CD 3 + CD 56 + natural killer T ( NKT )‐like cells are a subset of T cells characterized by expression of NK receptors and potent…”
Get full text

Association between CD 8 + T‐cell subsets and cardiovascular disease by Kolbus, D., Ljungcrantz, I., Andersson, L., Hedblad, B., Fredrikson, G. N., Björkbacka, H., Nilsson, J.

“…Abstract Background The findings of experimental studies suggest that the immune system plays a key role in atherosclerosis, but the clinical importance of…”
Get full text

Prevention of trypsin-induced shock in rats by the pancreatic secretory trypsin inhibitor by Jönsson, P, Ljungcrantz, I, Ohlsson, K

“…Intravenously infused bovine trypsin, 75 mg kg-1 during 3 h, induced shock in rats which proved lethal. After 5 h, all the rats had died. In another group of…”
Get more information

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine: Atherosclerosis vaccine and Tregs by Wigren, M., Kolbus, D., Dunér, P., Ljungcrantz, I., Söderberg, I., Björkbacka, H., Fredrikson, G. N., Nilsson, J.

Get full text

The presence of elafin, SLPI, IL1-RA and STNFα RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation by U. Westin, M. Nystrom, I. Ljungcrantz, B. Eriksson, K. Ohlsson

“…BIOPSY samples of head and neck carcinomas were investigated with regard to elafin, secretory leukocyte protease inhibitor (SLPI), interleukin 1-recepto r…”
Get full text

Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice by Fredrikson, Gunilla Nordin, Lindholm, Marie W., Ljungcrantz, Irena, Söderberg, Ingrid, Shah, Prediman K., Nilsson, Jan

“…Background: Oxidation of LDL is associated with generation of autoantibodies against a large number of different aldehyde-modified peptide sequences in apo…”
Get full text

The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation by Westin, U, Nyström, M, Ljungcrantz, I, Eriksson, B, Ohlsson, K

“…Biopsy samples of head and neck carcinomas were investigated with regard to elafin, secretory leukocyte protease inhibitor (SLPI), interleukin 1-receptor…”
Get full text